KOPRAN vs NGLFINE: Stock Comparison

KOPRAN vs NGL FINE CHEMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

NGL FINE CHEM is the larger company by market capitalisation. KOPRAN shows a higher dividend yield and lower leverage, while NGL FINE CHEM shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KOPRAN leads 3; NGLFINE leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KOPRANNGLFINE

Valuation lens

What price are you paying?

Market CapContext only
₹1,120 Cr
₹1,804 Cr
P/E RatioNGLFINE has the lower reading
37.34x
30.41x
P/B RatioKOPRAN has the lower reading
1.76x
5.28x
EPSNGLFINE has the higher reading
₹1.39
₹29.78
Book ValueContext only
₹109.82
₹532.9
Dividend YieldKOPRAN has the higher reading
2.76%
0.07%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NGLFINE is the larger company
₹1,804 Cr vs ₹1,120 Cr
P/E Ratio
NGLFINE has a lower P/E
30.41x vs 37.34x
P/B Ratio
KOPRAN has a lower P/B
1.76x vs 5.28x
EPS
NGLFINE has higher earnings per share
₹29.78 vs ₹1.39
Dividend Yield
KOPRAN has a higher dividend yield
2.76% vs 0.07%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs -3.66%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs -71.88%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
1.79% vs -59.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKOPRANNGLFINE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKOPRANNGLFINE
Live Price₹232.54₹2,907.5
Day Change0.13%-1.13%
Volume6.61 L7,107
52-Week High₹239.6₹3,602
52-Week Low₹107₹1,271
Distance from 52W High-2.95%-19.28%

Valuation

MetricKOPRANNGLFINE
Market Cap₹1,120 Cr₹1,804 Cr
P/E Ratio37.34x30.41x
P/B Ratio1.76x5.28x
EPS₹1.39₹29.78
Book Value₹109.82₹532.9
Dividend Yield2.76%0.07%

Growth

MetricKOPRANNGLFINE
Revenue Growth (TTM YoY)-3.66%57.2%
EPS Growth (TTM YoY)-71.88%1,539.8%
Qtr Sales Growth-59.25%1.79%
Qtr Profit Growth0.33%11.83%

Profitability & Leverage

MetricKOPRANNGLFINE
ROE4.85%13.01%
ROCE4.89%10.54%
Net Margin3.78%9.59%
Operating Margin6.58%12.08%
Debt to Equity0.29x0.34x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKOPRANNGLFINE
Promoter Holding44.42%72.49% 0.25 pp
FII Holding0.51% 0.06 pp0.05% 0.02 pp
DII Holding0%0.02% 0.02 pp
Public Holding55.06% 0.06 pp27.43% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KOPRAN and NGL FINE CHEM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.